Shuntaro Kodama
Direktor/Vorstandsmitglied bei Junten Bio Co. Ltd.
Aktive Positionen von Shuntaro Kodama
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Junten Bio Co. Ltd.
 Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Direktor/Vorstandsmitglied | - | - |
DCI Partners KK
 DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | 20.05.2014 | - |
| Private Equity Investor | 20.05.2014 | - | |
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | 01.12.2019 | - |
Karriereverlauf von Shuntaro Kodama
Ehemalige bekannte Positionen von Shuntaro Kodama
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NOILE-IMMUNE BIOTECH INC. | Direktor/Vorstandsmitglied | - | - |
| KIDSWELL BIO CORPORATION | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Shuntaro Kodama
| University of Tsukuba | Graduate Degree |
| Tokyo University of Science | Graduate Degree |
Statistik
International
| Japan | 8 |
Operativ
| Director/Board Member | 5 |
| Graduate Degree | 2 |
| Private Equity Investor | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOILE-IMMUNE BIOTECH INC. | Health Technology |
| KIDSWELL BIO CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
DCI Partners KK
DCI Partners KK Investment ManagersFinance DCI Partners KK (DCI Partners) is a venture arm of Daiwa Corporate Investment Co., Ltd. founded in 2014. The firm is headquartered in Tokyo, Japan. | Finance |
Junten Bio Co. Ltd.
Junten Bio Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Junten Bio Co. Ltd. is a Japanese company founded in 2018 that engages in research and development of cell and regenerative medicines. The company is based in Chuo-ku, Japan. | Commercial Services |
- Börse
- Insiders
- Shuntaro Kodama
- Erfahrung